Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

被引：0
|
作者：
Ohoud Aljuhani
Khalid Al Sulaiman
Adel Alshabasy
Khalid Eljaaly
Abdulrahman I. Al Shaya
Haytham Noureldeen
Mohammed Aboudeif
Bodoor Al Dosari
Amina Alkhalaf
Ghazwa B. Korayem
Muneera M. Aleissa
Hisham A. Badreldin
Shmeylan Al Harbi
Abdullah Alhammad
Ramesh Vishwakarma
机构：
[1] King Abdulaziz University,Department of Pharmacy Practice, Faculty of Pharmacy
[2] King Abdulaziz Medical City,Pharmaceutical Care Department
[3] King Abdulaziz University,Department of Anesthesia and Intensive Care
[4] King Saud Bin Abdulaziz University for Health Sciences,College of Pharmacy
[5] King Abdullah International Medical Research Center,Pharmaceutical Care Department
[6] King Abdulaziz University Hospital,College of Pharmacy
[7] Princess Nourah Bint Abdulrahman University,Department of Clinical Pharmacy, College of Pharmacy
[8] King Saud University,College of Pharmacy
[9] University of Arizona,Department of Anesthesia and Intensive Care
[10] Brigham and Women’s Hospital,undefined
[11] Ain Shams University,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
COVID-19; SARS-Cov-2; Tocilizumab; Secondary infection; CRE; Critically ill; Intensive care units (ICUs); Immunomodulatory drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Alshabasy, Adel
    Eljaaly, Khalid
    Al Shaya, Abdulrahman I.
    Noureldeen, Haytham
    Aboudeif, Mohammed
    Al Dosari, Bodoor
    Alkhalaf, Amina
    Korayem, Ghazwa B.
    Aleissa, Muneera M.
    Badreldin, Hisham A.
    Al Harbi, Shmeylan
    Alhammad, Abdullah
    Vishwakarma, Ramesh
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [2] The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Korayem, Ghazwa
    Alharbi, Aisha
    Altebainawi, Ali F.
    Aldkheel, Shatha A.
    Alotaibi, Sarah G.
    Vishwakarma, Ramesh
    Alshareef, Hanan
    Alsohimi, Samiah
    AlFaifi, Mashael
    Al Shaya, Abdulrahman
    Alhaidal, Haifa A.
    Alsubaie, Raghad M.
    Alrashidi, Hessah
    Albarqi, Khalid J.
    Alangari, Dalal T.
    Alanazi, Reem M.
    Altaher, Noora M.
    Al-Dorzi, Hasan M.
    RENAL FAILURE, 2023, 45 (02)
  • [3] Efficacy of tocilizumab in critically ill COVID-19 patients: a retrospective cohort
    Sadaf, Sairah
    Bashir, Babar
    Haider, Syeda Sabahat
    Mustafa, Ghulam
    Naqvi, Syed Aushtar Abbas
    ANAESTHESIA PAIN & INTENSIVE CARE, 2021, 25 (03) : 295 - 302
  • [4] Baricitinib versus tocilizumab in critically ill COVID-19 patients: A retrospective cohort study
    Conroy, Grace M.
    Bauer, Seth R.
    Pallotta, Andrea M.
    Duggal, Abhijit
    Wang, Lu
    Sacha, Gretchen L.
    PHARMACOTHERAPY, 2024, 44 (01): : 28 - 38
  • [5] The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
    Korayem, Ghazwa B.
    Aljuhani, Ohoud
    Altebainawi, Ali F.
    Al Shaya, Abdulrahman, I
    Alnajjar, Lina, I
    Alissa, Abdulrahman
    Aldhaeefi, Mohammed
    Kensara, Raed
    Al Muqati, Hessa
    Alhuwahmel, Abdulmohsen
    Alhuthaili, Omar
    Vishwakarma, Ramesh
    Aldardeer, Namareq
    Eljaaly, Khalid
    Alharbi, Aisha
    Al Harbi, Shmeylan
    Al Katheri, Abdulmalik
    Al Bekairy, Abdulkareem M.
    Aljedai, Ahmed
    Al Sulaiman, Khalid
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 252 - 259
  • [6] Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study
    Huang, Edmund
    Isonaka, Sharon
    Yang, Haoshu
    Salce, Erin
    Rosales, Elisa
    Jordan, Stanley C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 245 - 251
  • [7] Tocilizumab: A retrospective multi-center cohort study of critically ill patients with COVID-19
    Santos, Claudia R. Villatoro
    Bhargava, Ashish
    Coyle, Meredith
    Szpunar, Susan
    Saravolatz, Louis D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (11) : 705 - 712
  • [8] Tocilizumab in critically ill COVID-19 patients: An observational study
    Mushtaq, Muhammad Z.
    Mahmood, Saad B. Z.
    Almas, Aysha
    Wasti, Syed Ather
    Ali, Syed Ahsan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 102
  • [9] Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
    Wu, Ming
    Ji, Jing-jing
    Zhong, Li
    Shao, Zi-yun
    Xie, Qi-feng
    Liu, Zhe-ying
    Wang, Cong-lin
    Su, Lei
    Feng, Yong-wen
    Liu, Zhi-feng
    Yao, Yong-ming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [10] Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
    Mussini, Cristina
    Cozzi-Lepri, Alessandro
    Meschiari, Marianna
    Franceschini, Erica
    Burastero, Giulia
    Faltoni, Matteo
    Franceschi, Giacomo
    Iadisernia, Vittorio
    Volpi, Sara
    Dessilani, Andrea
    Gozzi, Licia
    Conti, Jacopo
    Del Monte, Martina
    Milic, Jovana
    Borghi, Vanni
    Tonelli, Roberto
    Brugioni, Lucio
    Romagnoli, Elisa
    Pietrangelo, Antonello
    Corradini, Elena
    Girardis, Massimo
    Busani, Stefano
    Cossarizza, Andrea
    Clini, Enrico
    Guaraldi, Giovanni
    VIRUSES-BASEL, 2023, 15 (02):
12345